• sales@syndicatedanalytics.com
  • +1-213-316-7435

US Plasma Therapeutics Market Research Report and Forecast 2018- 2023



“US Plasma Therapeutics Market Research Report and Forecast 2018- 2023” provides a deep and thorough evaluation of the plasma therapeutics market in the United States on the basis of fractionation products of plasma (Human Albumin, Plasma Derived Coagulation Factors, Immunoglobulins, Hyperimmune Globulins and A1PI) and disease type (Clotting Disorders, Immune Disorders, AATD and Others). The report also analyses the competitive structure of the US plasma therapeutics industry and provides the profiles of major players operating in the market.

Beginning with a regional overview, the report explores the dynamics that have a strong influence on the US plasma therapeutics market and also impact its future growth. Taking 2018 as the base year, the report covers historical market scenario from 2010-2017 and provides forecasts till 2023. This includes the study of value and volume trends as well as pricing history. Growth inducing factors, market restraints and recent developments have also been analyzed in the report in order to provide deeper knowledge about the industry.

US Plasma Therapeutics Market Key Segments

Segmentation by Fractionation Products of Plasma

  • Human Albumin
  • Plasma Derived Coagulation Factors
  • Immunoglobulins
  • Hyperimmune Globulins
  • A1PI

Segmentation by Disease Type

  • Clotting disorders
  • Immune disorders
  • AATD
  • Others

The price margins for the products along with various success and risk factors for manufacturers have also been covered in the report. Moreover, in order to determine market attractiveness, the report analyses the US plasma therapeutics industry along the parameters of the Porter’s Five Forces model. This model examines the degree of competition in the US plasma therapeutics market by analyzing the threats posed by new entrants and substitutes, and the bargaining power of suppliers and buyers. SWOT analysis of the market has also been presented in the report which highlights the strengths, weaknesses, opportunities and threats pertaining to the plasma therapeutics industry. Furthermore, the value chain analysis of the plasma therapeutics industry has also been covered in the report. This comprises of all the activities in the value chain, such as the procurement of various raw materials, manufacturing and sales of the products, and their distribution.

Key questions answered in the report include

  • What is the historical and current scenario of the US plasma therapeutics market?
  • What are the trends and developments in the US plasma therapeutics market?
  • What is the market forecast of the US plasma therapeutics market during 2018-2023?
  • What is the price analysis and forecast of the US plasma therapeutics market?
  • What is the Porter’s five forces analysis of the US plasma therapeutics market?
  • What is the SWOT analysis for the US plasma therapeutics market?
  • What is the value chain analysis of the US plasma therapeutics market?


The report is a result of exhaustive primary and secondary research undertaken by analysts having years of experience in the plasma therapeutics industry. All the qualitative and quantitative aspects of the industry have been covered and the collected data has been analyzed and presented in the form of easily comprehensible charts, graphs and tables.

1 Introduction 
    1.1 Research Objectives 
    1.2 Stakeholders
    1.3 Scope of the Report
    1.4 Assumptions and Limitations
2. Research Methodology 
    2.1. Data Collection
       2.1.1 Primary Sources
       2.1.2 Secondary Sources
    2.2 Market Size Estimation
        2.2.1 Bottom-Up Approach
        2.2.2 Top-Down Approach
    2.3 Data Validation
3. Executive Summary
4. United States Plasma Therapeutics Market

     4.1 Industry Overview
     4.2 Key Industry Developments
     4.3 Market Trends
        4.3.1 Key Market Indicators
        4.3.2 Historical Market Trends
        4.3.3 Market Forecast
     4.4 Price Analysis
        4.4.1 Key Price Indicators
        4.4.2 Pricing Structure
        4.4.3 Historical Price Trends
        4.4.4 Price Forecast
     4.5 Market Breakup by Fractionation Products of Plasma 
     4.6 Market Breakup by Disease Type 
5. United States Plasma Therapeutics Market: Value Chain Analysis
     5.1 Overview
     5.2 Research and Development
     5.3 Raw Material Suppliers
     5.4 Inbound Logistics
     5.5 Production
     5.6 Marketing 
     5.7 Outbound Logistics
     5.8 Consumers
6. United States Plasma Therapeutics Market: SWOT Analysis
     6.1 Overview
     6.2 Strengths
     6.3 Weaknesses
     6.4 Opportunities
     6.5 Threats
7. United States Plasma Therapeutics Market: Porter’s Five Forces Analysis
     7.1 Overview
     7.2 Threat of New Entrants
     7.3 Threat of Substitutes
     7.4 Bargaining Power of Buyers
     7.5 Bargaining Power of Suppliers
     7.6 Intensity of Rivalry
8.  Competitive Landscape
     8.1 Market Structure
     8.2 Key Players 
     8.3 Key Success Factors 
9 Key Player Profiles


List of Figures
    
Figure 1: United States: Plasma Therapeutics Market, 2010 - 2017
Figure 2: United States: Plasma Therapeutics Market Forecast, 2018 - 2023
Figure 3: United States: Plasma Therapeutics Market: Price Trends, 2010 - 2017
Figure 4: United States: Plasma Therapeutics Market Forecast: Price Trends, 2018 - 2023
Figure 5: United States: Plasma Therapeutics Market: Breakup by Fractionation Products of Plasma, 2017
Figure 5: United States: Plasma Therapeutics Market for Human Albumin, 2010, 2017 & 2023
Figure 5: United States: Plasma Therapeutics Market for Plasma Derived Coagulation Factors, 2010, 2017 & 2023
Figure 5: United States: Plasma Therapeutics Market for Immunoglobulins, 2010, 2017 & 2023
Figure 5: United States: Plasma Therapeutics Market for Hyperimmune Globulins,2010, 2017 & 2023
Figure 5: United States: Plasma Therapeutics Market for A1PI,2010, 2017 & 2023
Figure 6: United States: Plasma Therapeutics Market: Breakup by Disease Type, 2017
Figure 6: United States: Plasma Therapeutics Market for Clotting Disorders, 2010, 2017 & 2023
Figure 6: United States: Plasma Therapeutics Market for Immune Disorders, 2010, 2017 & 2023
Figure 6: United States: Plasma Therapeutics Market for AATD, 2010, 2017 & 2023
Figure 6: United States: Plasma Therapeutics Market for Others, 2010, 2017 & 2023
Figure 7: United States: Plasma Therapeutics Industry: Value Chain Analysis
Figure 8: United States: Plasma Therapeutics Industry: SWOT Analysis
Figure 9: United States: Plasma Therapeutics Industry: Porter’s Five Forces Analysis
Figure 10: United States: Plasma Therapeutics Market: Breakup by Key Players, 2017

    

List of Tables

Table 1: United States: Plasma Therapeutics Industry: Market Summary    
Table 2: United States: Plasma Therapeutics Industry: Market Overview, 2017 and 2023
Table 3: United States: Plasma Therapeutics Industry: Market Structure  
Table 4: United States: Plasma Therapeutics Market Forecast: Breakup by Fractionation Products of Plasma, 2018-2023
Table 5: United States: Plasma Therapeutics Market Forecast: Breakup by Disease Type, 2018-2023    
Table 6: United States: Plasma Therapeutics Market: Key Player

Special Prices


    Syndicated Analytics provides special pricing for:

  • Academic Institutes
  • Government Agencies
  • Nonprofit Organizations

  • For more information, feel free to contact us.





Related Reports

Garbage Bags Prefeasibility Analysis Report 2019

The report offers an in-depth roadmap or setting up a Garbage Bags manufacturing plant covering the essential techno-commercial aspects

Sanitary Napkins Prefeasibility Analysis Report 2019

The report offers an in-depth roadmap or setting up a Sanitary Napkins manufacturing plant covering the essential techno-commercial aspects.

Surgical Gloves Prefeasibility Analysis Report 2019

The report offers an in-depth roadmap or setting up a Surgical Gloves manufacturing plant covering the essential techno-commercial aspects

Linear Alkylbenzene Sulfonate Production Cost Analysis Report 2019

This production cost analysis report by Syndicated Analytics is the result of comprehensive examination of the Linear Alkylbenzene Sulfonate manufacturing process

GCC Healthcare Information Software Market by Development (On-Premise and Cloud) and Application (Hospitals, Clinics, Medical Research Centers and others):Industry Analysis, Trends, Growth and Forecast 2019-2024

The GCC Healthcare Information Software Market was worth US$ XX Billion in 2018, expanding at a CAGR of X% during 2011-2018. The market is projected to register a CAGR of X% during 2019-2024, reaching US$ XX Billion by 2024.